Activities of ABT-773 against Listeria monocytogenes and Coryneform Bacteria of Clinical Interest

AUTOR(ES)

Conejo, María del Carmen

FONTE

American Society for Microbiology

RESUMO

The in vitro activities of ABT-773 were evaluated against 15 Listeria monocytogenes strains and 196 coryneform bacteria isolated from clinical samples. One hundred percent of the L. monocytogenes strains were inhibited by ≤0.015 μg of ABT-773/ml. MICs of ABT-773 (μg/ml) at which 50% of the isolates tested were inhibited (MIC50s) and MIC90s for other organisms were 0.125 and 0.5 (Corynebacterium amycolatum), 1 and >32 (Corynebacterium jeikeium), 0.03 and >32 (Corynebacterium minutissimum), >32 and >32 (Corynebacterium pseudodiphtheriticum and Corynebacterium urealyticum), 0.125 and >32 (Corynebacterium striatum), and 0.03 and 0.5 (Rhodococcus equi), respectively.

Documentos Relacionados

• Comparative In Vitro Activities of ABT-773 against 362 Clinical Isolates of Anaerobic Bacteria
• Activities of ABT-773 against Microaerophilic and Fastidious Organisms
• In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas
• In Vitro Bactericidal Activities of ABT-773 against ermB Strains of Streptococcus pneumoniae
• Activities of Gemifloxacin and Five Other Antimicrobial Agents against Listeria monocytogenes and Coryneform Bacteria Isolated from Clinical Samples